Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
ADCs, TCEs among ‘exciting things’ on Boehringer's shopping list
Boehringer Ingelheim may have been on a spending spree so far this year—but the German pharma has plenty more items on its shopping list.
James Waldron
Apr 3, 2026 8:40am
Fierce Healthcare
White House floats 12.5% budget cut for HHS in FY2027
Apr 3, 2026 2:00pm
Syneron closes $150M round to support peptide platform
Apr 3, 2026 9:31am
Bayer radiology head takes top U.S. pharma spot—Chutes & Ladders
Apr 3, 2026 8:30am
Biopharma R&D pipeline shrinks for 1st time in 30 years: report
Apr 3, 2026 8:13am
Fierce Pharma
Trump slaps 100% duties on imported drugs, with exceptions
Apr 2, 2026 4:59pm
More News
Fierce Pharma
UK government agrees to pharma deal, ensuring tariff reprieve
Apr 2, 2026 3:34pm
Ferring terminates fertility trials after ‘portfolio assessment’
Apr 2, 2026 2:00pm
Stipple Bio debuts with $100M to advance oncology asset
Apr 2, 2026 10:00am
Epia launches to help stroke patients rework brain signals
Apr 2, 2026 10:00am
See more stories